This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-762MIMAT0010313 0.0e+0 4.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 3.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 5.0e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.4e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.9e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.4e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.8e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.5e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.3e-1Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs.
PLoS One. 2014 Nov 24;9(11):e113116. doi: 10.1371/journal.pone.0113116. eCollection 2014.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 5.7e-2Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs.
PLoS One. 2014 Nov 24;9(11):e113116. doi: 10.1371/journal.pone.0113116. eCollection 2014.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 1.8e-13Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 2.1e-12Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.8e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 3.2e-12Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 6.0e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 3.7e-11Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 3.6e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 1.2e-12Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 1.2e-6Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 5.9e-10Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 7.6e-12Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 1.2e-5Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 5.9e-9Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 9.0e-14Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 2.9e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 1.7e-9Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 1.1e-11Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 3.2e-7Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 1.7e-6Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 4.4e-10Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 2.4e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 5.2e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 3.6e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 6.8e-5Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 5.8e-8Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 4.0e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 7.3e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 4.2e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 1.9e-6Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 1.6e-9Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
gga-miR-762MIMAT0007752 0.0e+0 4.6e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mml-miR-762MIMAT0012791 0.0e+0 1.4e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
ptr-miR-762MIMAT0012815 0.0e+0 1.1e-8Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 7.2e-2Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 7.2e-2Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.1e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 3.7e-12 2.0e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.1e-11Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.1e-16Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.1e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 0.0e+0Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 4.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 3.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 3.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 4.1e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000624_160 / 0 / 60
mmu-miR-762MIMAT0003892 0.0e+0 1.3e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 2.6e-3 4.4e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 9.0e-4 4.4e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 3.4e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 3.6e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 8.4e-3 8.4e-3Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 9.0e-3 9.0e-3Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 1.3e-2Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 0.0e+0 5.3e-2Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 1.2e-3 1.2e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000624_160 / 0 / 60
hsa-miR-762MIMAT0010313 1.7e-3 1.7e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000624_160 / 0 / 60
< [2]